At the iwNHL 2014, Dr Steven Rosen (City of Hope National Medical Center, California, USA) describes the progress made in understanding the biology and management of non-Hodgkin lymphoma. Now, there is need to consider new drug combinations to maximise efficacy. Alternatives to chemotherapy including biologic approaches and future research directions including in precision medicine are examined.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content